Elusys Therapeutics and Lonza sign manufacturing agreement
<p>US-based Elusys Therapeutics and Lonza Sales in Switzerland have signed a production contract for Anthim, a therapeutic monoclonal antibody in late stage development for the treatment of anthrax infection. </p>